+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Biofilms Treatment Market by Product (Debridement Equipment, Gauzes & Dressings, Gels, Ointments & Sprays), Wound Type (Burns & Open Wounds, Diabetic Foot Ulcers, Pressure Ulcers), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5592112
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biofilms Treatment Market size was estimated at USD 2.92 billion in 2023, USD 3.18 billion in 2024, and is expected to grow at a CAGR of 9.31% to reach USD 5.45 billion by 2030.

Biofilm treatment in the medical sector is a form of therapy that targets microbial biofilms composed of clusters of bacteria and microorganisms. Biofilms can form on wounds or other areas of skin where infection has occurred. The biofilm treatment controls the growth and spread of these microorganisms and ultimately reduces the risk of infection. Treatment involves using antibiotics, antifungals, or other antimicrobial compounds to break up or inhibit the growth of biofilms. The rising prevalence of surgical and diabetic wounds and growing concern regarding biofilm infections raise the need for efficient biofilm treatment. However, concerns related to the resistance of biofilm-associated organisms to antimicrobial agents may reduce the effectiveness of the biofilm treatment. Moreover, advances in biofilm treatment and ongoing research on biofilm infections are expected to ensure the development of effective and enhanced biofilm treatment.

Regional Insights

The presence of well-established medical facilities and the growing need for efficient management of chronic wounds are resulting in the need for effective biofilm treatment in the Americas. The ongoing investments in R&D to develop new therapies for biofilms, such as antimicrobial agents, enzymes, and drug delivery systems, encourage the development of novel biofilm treatment methods in the Americas. The prevalence of diabetes and the presence of well-established pharmaceutical manufacturing industries, coupled with growing awareness among healthcare professionals about new technologies, are improving access to biofilm treatment in the APAC region. Substantial government support for research activities related to biofilm infections has resulted in increased R&D leading to the development of new therapies across multiple countries within the EMEA region. Besides, the introduction of advanced products and growing emphasis on producing novel drugs and treatments are anticipated to improve biofilm treatment worldwide.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biofilms Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biofilms Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biofilms Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Aroa Biosurgery, Ltd, Arobella Medical, LLC, Avery Dennison Corporation, B. Braun Melsungen AG, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group PLC, DEBx Medical BV, Ecolab Inc., Essity AB, Garwood Medical Devices, LLC, Integra LifeSciences Corporation, Kane Biotech Inc., Medaxis AG, Mediq B.V., Medline Industries, LP, Mil Laboratories Pvt. Ltd., MIMEDX Group, Inc., Molnlycke Health Care AB, Next Science Ltd., Organogenesis Inc., Paul Hartmann AG, Pulsecare Medical LLC, RLS Global AB, Sanara MedTech Inc., Smith & Nephew PLC, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Biofilms Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Debridement Equipment
    • Gauzes & Dressings
    • Gels, Ointments & Sprays
    • Grafts & Matrices
    • Wipes, Pads & Lavage Solutions
  • Wound Type
    • Burns & Open Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Traumatic & Surgical Wounds
    • Venous Leg Ulcers
  • End User
    • Home Care Settings
    • Hospitals, ASCs & Wound Care Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Biofilms Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biofilms Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Biofilms Treatment Market?
  4. What is the market share of the leading vendors in the Biofilms Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Biofilms Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biofilms Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of surgical and traumatic wounds
5.1.1.2. Rising incidence of burn injuries and wounds worldwide
5.1.1.3. Increasing diabetic population and need for efficient tretamnet of diabetic foot ulcer
5.1.2. Restraints
5.1.2.1. Structural complexity associated with biofilm treatment
5.1.3. Opportunities
5.1.3.1. Ongoing advancement in biofilms treatment technologies
5.1.3.2. Strategic alliances and investments to expand reserach on biofilm infections
5.1.4. Challenges
5.1.4.1. Concerns related to the resistance of biofilm-associated organisms to antimicrobial agents
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Biofilms Treatment Market, by Product
6.1. Introduction
6.2. Debridement Equipment
6.3. Gauzes & Dressings
6.4. Gels, Ointments & Sprays
6.5. Grafts & Matrices
6.6. Wipes, Pads & Lavage Solutions
7. Biofilms Treatment Market, by Wound Type
7.1. Introduction
7.2. Burns & Open Wounds
7.3. Diabetic Foot Ulcers
7.4. Pressure Ulcers
7.5. Traumatic & Surgical Wounds
7.6. Venous Leg Ulcers
8. Biofilms Treatment Market, by End User
8.1. Introduction
8.2. Home Care Settings
8.3. Hospitals, ASCs & Wound Care Centers
9. Americas Biofilms Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biofilms Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Biofilms Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Investment & Funding
12.3.1.1. TVM Capital Healthcare announces Euro 10 M investment in DEBx Medical
12.3.2. Award, Recognition, & Expansion
12.3.2.1. Innoviva gets FDA nod for pneumonia antibiotic
12.3.2.2. BlastX Antimicrobial Biofilm Wound Gel Now Available in Australia
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Aroa Biosurgery, Ltd
13.1.3. Arobella Medical, LLC
13.1.4. Avery Dennison Corporation
13.1.5. B. Braun Melsungen AG
13.1.6. Cardinal Health, Inc.
13.1.7. Coloplast A/S
13.1.8. ConvaTec Group PLC
13.1.9. DEBx Medical BV
13.1.10. Ecolab Inc.
13.1.11. Essity AB
13.1.12. Garwood Medical Devices, LLC
13.1.13. Integra LifeSciences Corporation
13.1.14. Kane Biotech Inc.
13.1.15. Medaxis AG
13.1.16. Mediq B.V.
13.1.17. Medline Industries, LP
13.1.18. Mil Laboratories Pvt. Ltd.
13.1.19. MIMEDX Group, Inc.
13.1.20. Molnlycke Health Care AB
13.1.21. Next Science Ltd.
13.1.22. Organogenesis Inc.
13.1.23. Paul Hartmann AG
13.1.24. Pulsecare Medical LLC
13.1.25. RLS Global AB
13.1.26. Sanara MedTech Inc.
13.1.27. Smith & Nephew PLC
13.1.28. Zimmer Biomet
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. BIOFILMS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. BIOFILMS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOFILMS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOFILMS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOFILMS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOFILMS TREATMENT MARKET DYNAMICS
FIGURE 7. BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2023 VS 2030 (%)
FIGURE 10. BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOFILMS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BIOFILMS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BIOFILMS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BIOFILMS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • 3M Company
  • Aroa Biosurgery, Ltd
  • Arobella Medical, LLC
  • Avery Dennison Corporation
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Coloplast A/S
  • ConvaTec Group PLC
  • DEBx Medical BV
  • Ecolab Inc.
  • Essity AB
  • Garwood Medical Devices, LLC
  • Integra LifeSciences Corporation
  • Kane Biotech Inc.
  • Medaxis AG
  • Mediq B.V.
  • Medline Industries, LP
  • Mil Laboratories Pvt. Ltd.
  • MIMEDX Group, Inc.
  • Molnlycke Health Care AB
  • Next Science Ltd.
  • Organogenesis Inc.
  • Paul Hartmann AG
  • Pulsecare Medical LLC
  • RLS Global AB
  • Sanara MedTech Inc.
  • Smith & Nephew PLC
  • Zimmer Biomet

Methodology

Loading
LOADING...

Table Information